Boxer Capital’s Voyager Therapeutics VYGR Stock Holding History

Boxer Capital’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-500,000	Closed	-$8.61M	–	57
2019 Q3	$8.61M	Buy	500,000 +400,000	+400%	+$8.4M	0.62%	32
2019 Q2	$2.72M	Buy	+100,000	New	+$2.29M	0.23%	35

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Boxer Capital's VYGR Position: Q4 2019 in Review

Boxer Capital sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 500,000 shares — an estimated $8.61M sold.

Boxer Capital first reported a position in VYGR in Q2 2019 and held it in 2 quarters. The position peaked at $8.61M in Q3 2019. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

Boxer Capital reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
Boxer Capital sold 500,000 Voyager Therapeutics shares in Q4 2019, an estimated $8.61M.
Boxer Capital first reported a position in Voyager Therapeutics in Q2 2019 and held it in 2 quarters.
Boxer Capital's Voyager Therapeutics position peaked at $8.61M in Q3 2019.
138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Boxer Capital's 13F filing for Q4 2019, filed 14 Feb 2020.